CUSIP: 72942A107
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,250,710
-
Share change
-
+3,781,314
-
Total reported value
-
$106,137,652
-
Put/Call ratio
-
47%
-
Price per share
-
$8.01
-
Number of holders
-
56
-
Value change
-
+$18,883,806
-
Number of buys
-
34
-
Number of sells
-
27
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 72942A107:
Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q4 2021
As of 31 Dec 2021,
PLX PHARMA INC - COM (PLXPQ) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,250,710 shares.
The largest 10 holders included
MSD Partners, L.P., Park West Asset Management LLC, VANGUARD GROUP INC, MORGAN STANLEY, TWO SIGMA ADVISERS, LP, GW&K Investment Management, LLC, TWO SIGMA INVESTMENTS, LP, BlackRock Inc., FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., and FRIESS ASSOCIATES LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.